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TGF super-family proteins, acting via SMAD2/3 pathways, regulate placental function, however,
the role of SMAD1/5/8 pathway in the placenta is unknown. This study investigated the functional
role of BMP4 signaling through SMAD1/5 in terminal differentiation of primary chorionic gonad-
otropin (CG)-secreting trophoblast. Primary equine trophoblast cells or placental tissues were
isolated fromday 27–34 equine conceptuses. Detected bymicroarray, RT-PCR andqRT-PCR, equine
chorionic girdle trophoblast showed increasedgeneexpressionof receptors that bindBMP4.BMP4
mRNA expression was 20–60 fold higher in placental tissues adjacent to the chorionic girdle
compared to chorionic girdle itself suggesting BMP4 acts primarily in a paracrine manner on the
chorionic girdle. Stimulation of chorionic girdle-trophoblast cells with BMP4 resulted in a dose-
dependent and developmental stage-dependent increase in total number and proportion of ter-
minally differentiated binucleate cells. Furthermore, BMP4 treatment induced non-CG secreting
day 31 chorionic girdle trophoblast cells to secrete CG, confirming a specific functional response to
BMP4 stimulation. Inhibition of SMAD2/3 signaling combined with BMP4 treatment further en-
hanced differentiation of trophoblast cells. Phospho-SMAD1/5, but not phospho-SMAD2, expres-
sion as determined by western blotting was tightly regulated during chorionic girdle trophoblast
differentiation in vivo, with peak expression of pSMAD1/5 in vivo noted at day 31 corresponding
to maximal differentiation response of trophoblast in vitro. Collectively, these experiments dem-
onstrate the involvement of BMP4-dependent pathways in the regulation of equine trophoblast
differentiation in vivo and primary trophoblast differentiation in vitro via activation of SMAD1/5
pathway; a previously unreported mechanism of TGF signaling in the mammalian placenta.
Placental trophoblast cells perform nutritional, endo-crine and immunomodulatory functions essential to
the survival of the developing fetus. Mammalian tropho-
blast differentiation is tightly regulated through the ex-
pression of transcription factors (intrinsic regulators),
growth factors (extrinsic regulators) and components of
their associated signaling pathways (1). Chorionic gonad-
otropin (CG) is secreted by both horse and human pla-
centa and is critical to maintenance of early pregnancy.
Production of CG is dependent on the differentiation of
specialized CG-secreting cells, binucleate (horse) and syn-
cytiotrophoblast (human) (2, 3). These two cell types
share the expression of the transcription factor Glial Cells
Missing 1 (GCM1), which is rapidly induced in vivo dur-
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ing differentiation of both equine and human trophoblast
(3, 4). The extrinsic factors that regulate terminal differ-
entiation of primary equine binucleate trophoblast cells
and CG secretion remain elusive.
The chorionic girdle is a unique transient structure of
the equine placenta that gives rise to the endometrial cups.
Development of the equine chorionic girdle begins around
day 25 of gestation, at which time the uninucleate tropho-
blast cells undergo a period of rapid proliferation (2). Pre-
vious studies of cell morphology (5) and the kinetics of
eCG expression (3, 6), indicate that induction of terminal
differentiation of the binucleate trophoblast cells begins
around day 31 of pregnancy. The number of binucleate
cells then rapidly increases until around day 36–38 (7–
10). Several growth factors including Epidermal Growth
Factor (EGF), Vascular Endothelial Growth Factor
(VEGF), Hepatocyte Growth Factor-Scatter Factor
(HGF-SF) and Transforming Growth Factor  1 (TGF1)
are expressed by the equine endometrium and avascular
mesoderm that abut the chorionic girdle (11–16), re-
viewed by (17), but the functional role of these growth
factors in differentiation of chorionic girdle trophoblast is
not known.
TGF- proteins are expressed at the fetal-maternal in-
terface during human pregnancy and are implicated in the
promotion of pre- and postimplantation embryonic de-
velopment (18). BoneMorphogenetic Protein 4 (BMP4) is
amember of theTGF- ligand superfamilywhich is a large
family of dimeric proteins with multifunctional roles in-
cluding cellular proliferation, differentiation, migration
and apoptosis (19). BMP4 functions through binding to
and phosphorylating a type I and II serine/threonine ki-
nase receptor, resulting in the activation of downstream
intracellular signals via phosphorylation of the receptor
regulated SMAD1/5/8 transcription factors, which com-
plexwith SMAD4 to initiate transcription (19, 20). BMP4
signaling can bemodified through a number of regulatory
inputs, namely availability of the ligand (BMP4), re-
stricted expression of specific type I (bone morphogenetic
protein receptor, type IA and bonemorphogenetic protein
receptor, type IA, BMPR1A and BMPR1B), and type II
(Bone morphogenetic protein receptor type II, BMPR2)
receptors, and the presence of the inhibitory pseudorecep-
tor, BMPandactivinmembranebound inhibitor (BAMBI)
(21).TGF signaling throughSMAD2/3proteinshasbeen
described in a number of studies in normal and pre-
eclamptic placentae (22–29). In contrast, little is known
about the function of ligands that signal through SMAD1/
5/8 proteins, such as BMP4. Trophoblast lineages have
been generated from human embryonic stem cells (ESC)
derived from human blastocysts ‘primed’ by BMP4 sup-
plementation alone or in combination with other factors
(30–39). However, the role of BMP4-dependent
SMAD1/5 signaling in differentiation of primary tropho-
blast cells in vitro and in vivo is not known.
There is restrictedavailabilityofhumanplacental tissue
during early pregnancy and controversy about the avail-
ability of in vitro systems that can adequately serve as a
model for early events in the human placenta (reviewed by
(40)), a period in development when embryonic losses are
high (41). Studies in the horse may also prove informative
to our understanding of the fundamental mechanisms of
human trophoblast differentiation (42). CG is a hormone
secreted uniquely by the horse andhumanplacenta critical
to the maintenance of pregnancy. Equine binucleate tro-
phoblast cells and human syncytiotrophoblast cells share
expression of growth factors, transcription factors and
components of their associated signaling pathways (3, 4,
42). Further, we have previously shown that it is possible
to exploit the late implantation of the equine placenta to
isolate pure populations of trophoblast cells at multiple
stages of binucleate trophoblast development from the
same stallion/mare combination (3). These features of
equine pregnancy provide us with a unique resource to
dissect molecular events that regulate differentiation of
chorionic gonadotrophin-secreting trophoblast cells in
vivo, and so integrate molecular data with physiological
function.
In this study we investigated the role of BMP signaling
pathways in equine chorionic girdle trophoblast differen-
tiation in vitro and in vivo. Specifically, we elucidate a role
for BMP4 in the regulation of terminal differentiation of
and subsequent CG secretion from trophoblast cells of the
chorionic girdle via activation of the SMAD1/5/8 path-
way. Furthermore, we show that when the SMAD 2/3
pathway is inhibited, BMP4 induced terminal differenti-
ation of CG-secreting trophoblast cells is further
increased.
Materials and Methods
Animals
Mares aged 3–7 years were maintained at the Royal Veteri-
nary College and animal care was performed in accordance with
theAnimals (Scientific Procedures)Act1986guidelines set by the
HomeOffice andEthicsCommittee of theRoyalVeterinaryCol-
lege. The reproductive cycle was manipulated and pregnancies
were established as previously described using semen from three
stallions (3).
Tissue collection
Conceptuses were recovered by nonsurgical uterine lavage
with established methods (3) between Days 27 and 34 of preg-
nancy. Three or four conceptuses per development stage were
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collected for each individual experiment. The sex of the concep-
tuseswas not determined. Conceptusesweremicrodissected into
chorionic girdle, allantochorion, chorion, yolk sac, bilaminar
omphalopleure and fetus. Human first trimester placental tissue
was obtained as previously described (43) (Wandsworth Local
Research Ethics Committee approval ref: 01.96.8).
Culture and stimulation of trophoblast cells
To gain a pure population of trophoblast cells, strips of cho-
rionic girdle were placed into Dulbecco modified Eagle medium
(DMEM) and the chorionic girdle trophoblast cells gently re-
moved from basement membrane and underlying avascular me-
sodermal cell layer and cultured as per published methods (8).
Cells were supplemented with 1–100 ng/ml human recombinant
BMP4 (R&DSystems) or an equivalent volume of PBS/BSA. The
A83–01 inhibitor, selective for Activin receptor type-1B
(ACVR1B), Transforming Growth Factor, Beta Receptor 1
(TGFBR1) andActivin AReceptor, Type IC (ACVR1C) (Tocris,
Bristol, UK), was used at a final concentration of 1 M. Media
was harvested after 72 hours, and supernatant aliquoted and
stored at –20°C.
Quantification of binucleate cell differentiation
and eCG secretion
Binucleate differentiation was quantified by measurement of
the number of nuclei per cell using CellTraceTM BoDIPR® TR
methyl ester and nuclear stain Hoechst and subsequent fluores-
cent microscopy after 72 hours in culture. Using a fluorescent
microscope, 5 images per well captured and analyzed using Im-
age J to ascertain the total number of binucleate cells within each
image. The concentration of eCG in medium recovered from
cultured chorionic girdle cells after 3 days in culture was deter-
mined using a PMSG enzyme liked immunoassay (DRG Inter-
national), as previously described (44).
RNA Isolation and cDNA Synthesis
Total RNA was isolated from snap-frozen equine conceptus
tissue, and human placental tissue stored in RNAlater (Invitro-
gen), following homogenization by QIAshredder (Qiagen, Va-
lencia, CA), using an RNeasy kit (Qiagen) as directed by the
manufacturer. Five hundred nanograms of RNA was DNase I
treated (Invitrogen, Carlsbad, CA), and first-strand cDNA syn-
thesis performed using M-MLV Reverse Transcriptase (USB,
Cleveland, OH) as per the manufacturer’s guidelines.
RT-PCR, qRT-PCR and Microarray
PCR was performed using standard methods. Amplification
of 15 ng of cDNA was performed in a 20 l reaction using 10X
PCR Buffer, 0.2 mM each dNTP, 1.5 mM MgCl (Invitrogen),
0.25 Meach primer, and 1.25 l recombinant Taq DNA Poly-
merase (Invitrogen).Cyclingparameters forPCRwere as follows
for all amplified cDNAs: an initial denaturation stepof 2minutes
at 94°C, followed by 35 cycles of 30 seconds at 94°C, 30 seconds
at 59°C and 1 minute at 72°C, and a final extension step of 10
minutes at 72°C. Ten microliters of each PCR reaction were run
on a 1% (w/v) agarose gel to visualize PCR products. The PCR
products were purified, cloned, and sequenced to confirm the
specificity of the PCR product. Primer sequences are shown in SI
Table 2.
Real-time RT-PCR reactions for amplification of equine
BMP4, BMPR2, BMPRIA, BAMBI, RGM domain family mem-
ber B (DRAGON) or the housekeeper gene equine Succinate
Dehydrogenase Complex, Subunit A, Flavoprotein (SDHA)
mRNA were performed using SYBR Green chemistry (KAPA
SYBR FAST Universal qPCR kit, KAPA Biosystems). PCR was
carried out using aC-1000 thermal cycler andCFX-96Real time
system (BioRad) in a total volume of 20 l. PCR reactions were
carried out for 38 cycles of 30 seconds at 95°C, 30 seconds at
60°C, 20 seconds at 72°C. A melting curve was set to run from
60°C-95°C. A dissociation curve was performed after each ex-
periment to confirm that a single product was amplified. For
BMP4 and SDHA, a standard curve was generated using known
copy numbers of purified PCR products for each gene. Each
sample was normalized relative to BMP4 copy number in the
chorionic girdle (spatial assay). For BMPRIA, BMPR2, BAMBI
and DRAGON, relative gene expression in days 27 to 34 cho-
rionic girdle was calculated using the Pfaffl method (45) taking
into account the efficiency of the reaction for each individual
gene. Primer sequences are shown in SI Table 3.Microarray data
used in this study has been previously reported (46).
Western blot analysis
Tissueswere groundand lysedon ice in lysis buffer containing
20mMTris-HCl (pH8), 300mMKCl, 1%NP-40 (v/v), 2.5 mM
EDTA, 1 mM VO4, 10% glycerol, with a protease inhibitor
cocktail (Minicomplete protease inhibitor, Roche). Protein con-
centrations were determined using Bradford assay (BioRad).
Protein from mouse spleen (positive control), chorionic girdle,
chorion, allantochorion and yolk sack was diluted with lysis
buffer.A total of40gproteinperwellwas loadedandseparated
by SDS-PAGE on a 10%(w/v) polyacrylamide gel before being
transferred to a nitrocellulose membrane using a Mini-PRO-
TEAN® Tetra cell wet transfer unit (Bio-Rad, USA). The mem-
branes were incubated overnight at 4°C in a 1/500 dilution of
rabbit antihuman Total SMAD5, pSMAD1/5, Total SMAD2
(Cell Signaling Technology,MA, USA), or pSMAD2 (Millipore,
CA, USA) polyclonal antibodies each in TBS–T containing 5%
(w/v) nonfat milk. Sequence alignment confirmed that the hu-
manpeptide sequences againstwhich the SMAD1/5andSMAD2
antibodieswere directed shared99, 100%and100%aminoacid
identities with the corresponding regions of equine SMAD1,
SMAD5 and SMAD2 respectively. Membranes were incubated
with a 1/10000 dilution of goat antirabbit IgG secondary anti-
body conjugated to horseradish peroxidase (Sigma, UK) in
TBS–T containing 5% (w/v) nonfat milk. SMAD proteins were
visualized by incubating with ECL plus detection reagents (Per-
kin Elmer, UK) and exposed onto Hyperfilm ECL. To confirm
integrity of protein transfer, and as a loading control, mem-
branes were stripped and reprobed for -actin using a monoclo-
nal mouse -actin antibody (Sigma, UK) at a dilution of 1/5000.
Densitometry analysis of Western blots was carried out using
ImageJ 1.47b software.
Statistics
All statistical tests were performed by using GraphPad Prism
4 statistical software, version 6 (GraphPad, San Diego, Calif.,
USA). Each experiment was repeated three to four times with
tissue from a different conceptus on each occasion. Having con-
firmed the distribution of each data set, themean (of means) and
SEMwere calculated for each experimental condition across the
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three to four biological replicates. Quantification of temporal
BMP4 expression temporally and SMADprotein expressionwas
compared between the number of days gestation by using one-
way analysis of variance (ANOVA) with repeated measures and
the post hocTukey’smultiple comparison test.Quantification of
BMP4 expression spatially was compared between tissues and
was analyzed by one sample t test. BMPRIA, BMPR2, BAMBI,
Dragon andBMP4 expression in day 27–34 chorionic girdlewas
compared using Kruskal-Wallis one-way ANOVA. The total
number of binucleate trophoblast cells was compared both be-
tween thenumberof days gestationusingone-wayANOVAwith
repeated measures and the post hoc Tukey multiple comparison
test, or, by both time and treatment, using repeated measures by
two factors followedbyTukeyor Sidakmultiple comparison test
where appropriate. P  .05 was accepted as statistically signif-
icant in all tests.
Results
Receptors for TGF superfamily ligands are tightly
regulated in the chorionic girdle
Using data generated with a 44 000 equine gene probe
expression array (46) relative expression of seven type I,
three type II and five accessory TGF superfamily recep-
tors in gestational day 34 chorionic girdle tissue was com-
pared to adjacent day 34 chorion tissue (Supplementary
Table 1). We searched for receptors that had increased
expression in the chorionic girdle (terminally differenti-
ated trophoblast that secrete CG) compared to chorion
(undifferentiated trophoblast that do not secrete CG. We
report that the chorionic girdle preferentially expresses
those receptors that are known to bind BMP2, BMP4 and
BMP7 (Supplementary Table 1).We found no evidence of
upregulated expression of either TGF1 specific type I
receptor (TGFR1) or its type II receptor (TGFBR2), nei-
ther didwe find evidence for the expression of its SMAD1/
5/8 specific pathway type I receptor activin receptor type-
II-like I (ACVRL1). Transforming growth factor beta
receptor III (TGFBR3) and endoglin (ENG), both associ-
ated accessory receptors to TGF1, were down regulated
in the chorionic girdle (Supplementary Table 1).
Using RT-PCR, we confirmed expression of the type I
receptor BMPR1A and type II receptor BMPR2 in chori-
onic girdle tissue at day 27, 30, 31 and 34; prior to and
during the period of binucleate cell differentiation in vivo
(Figure 1A). BMPR1B was not detected in any of the cho-
rionic girdle tissues tested. These results suggest that in
these chorionic girdle trophoblast cells, BMP may signal
through the BMPR1A and BMPR2dimer. The BMP4 spe-
cific accessory receptors: Dragon and BAMBI are also
expressed at day 27, 30, 31 and 34. As expected GCM1
mRNA expression, a marker of chorionic girdle tropho-
blast cells (3) was confined to the chorionic girdle tissue
and was not observed in positive control tissues. Quanti-
tative real time RT-PCR analysis was additionally used to
compare temporal expression of these receptors in the
chorionic girdle. There was no significant difference in
expression levels of BMPR2, BAMBI and Dragon in the
chorionic girdle (Figure 1B) between days 27 and 34 of
pregnancy. BMPRIA expression was modestly increased
in day 34 chorionic girdle (1.7 fold) when compared with
day 31 chorionic girdle (P  .05).
Figure 1. Temporal mRNA expression of type I, type II and
accessory receptors specific for the ligand BMP4 in
chorionic girdle tissue from day 27, 30, 31 and 34
conceptuses. A. Qualitative RT-PCR analysis of temporal receptor
expression in the chorionic girdle. Amplicons were generated using
primers specific for equine BMPR1A, BMPR1B, BMPR2, BAMBI,
DRAGON, GCM1 and BACTIN (as control) mRNA, and all bands
observed in all tissues with each primer set are of the correct predicted
size: 306, 343, 364, 264, 269, 450 and 346 bp respectively. The figure
shows typical RT-PCR product gels (n  3) in which the tissue-specific
mRNA expression profile was representative of three independent
chorionic girdles. NTC  no template control. Equine testis and
nonpregnant uterus were used as control tissues (lanes marked VE).
B. Real time QRT-PCR expression of BMPR1A, BMPR2, DRAGON and
BAMBI mRNA in day 27–34 chorionic girdle. Data points represent the
values for individual conceptuses (n  4, except for day 27 n  3 as
one sample failed to meet control gene validation parameters and was
excluded from the dataset).
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BMP4 stimulates terminal differentiation of
chorionic girdle trophoblast cells in vitro
Next, the number of binucleate trophoblast cellswithin
the pure population of chorionic girdle trophoblast cells
derived from day 30/31 conceptus’ (depicted in Figure 2A
and 2B) were quantified following culture in the absence
or presence of 1, 10, or 100 ng/ml BMP4 for 72h (Figure
2C). We observed a significant increase (P .01) in total
binuceate cell number when the chorionic girdle tropho-
blast cells were treated with 100 ng/ml recombinant hu-
Figure 2. Effects of BMP4 stimulation on terminal differentiation of chorionic girdle trophoblast. Pure populations of
chorionic girdle cells from four different stages of chorionic girdle development were cultured in the presence or absence of 1–100 ng/ml BMP4,
over 72 hours. The total number of binucleated cells was quantified in 5 randomly selected fields for each treatment group; the depicted pooled
data represent the mean (of means)  SEM for 3 individual conceptuses at each development stage. Representative images of A) vehicle treated
and B) 100 ng/ml BMP4 treated chorionic girdle trophoblast cells in culture stained with CellTrace and Hoeschst. C) Quantification of binucleate
trophoblast cells following culture in absence or presence of 1, 10, or 100 ng/ml BMP4 for 72h. D) ID1 mRNA expression in day 30 and day 31
trophoblast cells in the absence (V) or presence (BMP4) of 100 ng/ml BMP4. E) Quantification of binucleate cells following culture in the presence
(black bars) or absence (white bars) of 100 ng/ml BMP4 for 72h, derived from three different stages of chorionic girdle development or day 34 of
pregnancy (positive control). F) Equine CG secretion from chorionic girdle trophoblast cells treated in the absence or presence of 100 ng/ml BMP4
and measured by equine CG ELISA. Data represents mean /- SEM and were analyzed by repeated measures ANOVA followed by Tukey multiple
comparison test (** P  .01) relative to corresponding vehicle cells, or by repeated measures by two factors followed by Tukey or Sidak multiple
comparison test (* P  .05 ** P  .01 *** P  .001 relative to corresponding vehicle cells. P  .01 (D31 v D32/33) P  .001 (D30 v D31) relative
to corresponding 100 ng/ml BMP4 treated cells.
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man (rh) BMP4 (Figure 2C). To confirm that rh BMP4
treatment was biologically active on the equine chorionic
girdle trophoblast cells, we conducted RT-PCR for ID1, a
major transcriptional target of BMP signaling. In compar-
ison to vehicle treated cells, BMP4 stimulation resulted in
increased expression of ID1 mRNA in chorionic girdle
trophoblast cells in vitro (Figure 2D). Subsequently we
quantified the total number of binucleate cells following
culture in the presence or absence of 100 ng/ml BMP4 for
72h, at three different stages of chorionic girdle develop-
ment: day 30, 31 and 32/33 of gestation. Terminally dif-
ferentiated cells derived from a day 34 conceptuses acted
as a positive control (Figure 2E, F). The response to BMP4
treatment was dependent on the development stage.
BMP4 treatment significantly increased total binucleate
cell number at day 30 (P .05), day 31 (P .001) and day
32/33 (P .01) when compared to corresponding vehicle
treated cells (Figure 2E). Furthermore, the rate of differ-
entiation in day 31 chorionic girdle trophoblast cells was
significantly higher than in BMP4 treated cells from day
30 (P  .001) and day 32/33 (P  .01) chorionic girdle
(Figure 2E). Compared to vehicle treated cells, 100 ng/ml
BMP4 induced eCG secretion from immature non-CG se-
creting chorionic girdle cells at day 31, but not day 30
(Figure 2F), confirming a specific functional response to
BMP4 stimulation. Moreover, daily treatment of 100
ng/ml BMP4 for 3 days can significantly further stimulate
differentiation of day 30 cells compared to vehicle treated
cells (P .05), comparable to the differentiation rate seen
in day 31 cells (Figure 3). However, daily treatment of
BMP4 does not serve to further increase the total binu-
cleate cell numbers in day 31 chorionic girdle trophoblast
cells compared to a single dose of 100 ng/ml BMP4 and
visualized 72 hours later (Figure 2E and Figure 3).
Inhibition of SMAD2/3 pathway induces further
increases in terminal differentiation of chorionic
girdle trophoblast cells in vitro
We report that inhibition of the alternative SMAD2/3
signaling pathway with 1 M A83–01 (47) in combina-
tion with daily treatment of 100 ng/ml BMP4 for 3 days
results in a further increased rate of differentiation of cho-
rionic girdle trophoblast in vitro (Figure 3). In both day 30
and day 31 chorionic girdle trophoblast cells a minimum
of a 5-fold increase in cell differentiation was observed in
cells treated with both BMP4 and A83–01 when com-
pared to the corresponding vehicle treated cells (P .001,
P  .001, for both day 30 and day 31). Furthermore, a 2
fold-increase in the number of binucleate cells treatedwith
the combination treatment (BMP4 and A83–01) was ob-
served, when compared to the corresponding BMP4 alone
treated cells (P .001, P .001, for both day 30 and day
31). There was no significant difference between the re-
sponse observed in day 30 and day 31 either with BMP4
alone or when stimulated with BMP4 and A83–01.
The number of terminally differentiated cells in both
day 30 and day 31 chorionic girdle trophoblast cells was
significantly increased when the cells were treated with
A83–01 alone compared to vehicle (P .001) and relative
to the correspondingBMP4treated cells (day30;P .001,
and day 31; P .05) (Figure 3). In addition, there was no
significant difference in the number of terminally differ-
entiated cells in A83–01 alone stimulated day 30 cells
compared to the combination BMP4/A83–01 treatment,
whereas BMP4 had a significant additive effect in the
BMP4/A83–01 combination treated cells over A83–01
alone treated day 31 cells (P  .001).
SMAD1/5 signaling is activated during chorionic
girdle development in vivo
Antibodies directed against human phospho
SMAD1/5, human total SMAD1/5, human phospho
SMAD2/3 and human total SMAD2/3 and were able to
detect a single equine protein of approximately 60 kDa in
chorionic girdle of different developmental stages. We
subsequently report that there is a significant increase in
phosphoSMAD1/5at day30, fromday27, indicating that
SMAD1/5 signaling is activated during chorionic girdle
development in vivo and peaks at Day 31 corresponding
with the initiation of binucleate cell differentiation (Figure
4A, 4B). Furthermore, we observed very little total and
phospho SMAD1/5 in the chorion, indicating that regu-
lationof the SMAD1/5pathway is specific to the chorionic
Figure 3. Effect of daily treatment of BMP and SMAD2/3
pathway inhibitor A83–01 on terminal differentiation of
chorionic girdle trophoblast cells from day 30 and day 31
conceptuses. Pure populations of chorionic girdle cells were treated
daily for 3 days in the presence or absence of 100 ng/ml BMP4, 1 M
A83–01 inhibitor or both. The total number of binucleated cells was
quantified in 5 randomly selected fields for each treatment group; the
depicted pooled data represent the mean (of means)  SEM for 3
individual conceptuses at either gestational day 30 or day 31. Data
were analyzed by repeated measures by two factors followed by Tukey
multiple comparison test (* P  .05 ** P  .01 **** P  .0001
relative to corresponding vehicle cells. P  .05 P  .001 P  .0001
relative to corresponding 100ng/ml BMP4 treated cells. ### P  .001
relative to corresponding 100 ng/ml BMP4 plus 1 M inhibitor treated
cells.
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girdle (Figure 4A). There was no observed regulation of
the pSMAD 2/3 proteins in either chorionic girdle or cho-
rion tissue (Figure 4A and 4C).
BMP4 expression indicates the ligand may act on
the chorionic girdle primarily through paracrine
signaling in vivo
Having observed expression of the BMPR1A and
BMPR2 receptors in the chorionic girdle, a functional re-
sponse to BMP4 in vitro, and activation of SMAD1/5 sig-
naling in vivo,we then looked to seewhich of the placental
membranes expressed the ligandBMP4. In day 30/31 con-
ceptuses, BMP4 expression in the chorion and yolk sac
was 20–60 fold higher (P .05) than expression levels in
the chorionic girdle, with a trend towards higher expres-
sion in the allantochorion (P  .065) (Figure 5A). We
observed expression of BMP4mRNA at day 27 and 30 in
the chorionic girdle with no expression detectable by RT-
PCRat days 31 and34 (Figure 5B). SubsequentQRT-PCR
analysis showed that BMP4 mRNA expression was sig-
nificantly decreased at day 34 (10.9 fold) when compared
with day 30 chorionic girdle (P  .05) (Figure 5C).
Discussion
Implantation of the equine placenta occurs relatively late
in pregnancy and following differentiation of chorionic
girdle trophoblast cells that give rise to the CG-secreting
binucleate cells of the endometrial cups.Hereweexploited
these features of early equine pregnancy to study BMP4
Figure 4. SMAD signaling protein expression in chorionic
girdle and chorion tissue isolated from day 27, 30, 31 and
34 conceptuses. Western blots were probed with antibodies raised
against human peptide sequences in SMAD1/5 and pSMAD1/5, or
SMAD2, pSMAD2 and murine -actin (as controls) (A). Mouse spleen
was used as a positive control tissue (). Each Western blot was
quantified by densitometry (B, C) Data were analyzed by repeated
measures ANOVA followed by Tukey multiple comparison test (* P 
.05) relative to day 27 chorionic girdle (B, C). This representative panel
shows the pattern of immunoreactive proteins recognized in equine
chorionic girdle tissue protein preparations confirming that the
antibodies directed against the human SMAD1/5 and pSMAD 1/5,
SMAD2 and pSMAD2 recognized a single equine protein of
approximately 60 kDa. Each panel shows typical western blots in which
the tissue-specific protein expression profile was representative of
three conceptuses.
Figure 5. Temporal and spatial expression of BMP4 mRNA
in equine conceptus tissue. A. Quantitative spatial expression of
BMP4 mRNA in chorionic girdle (CG) and adjacent day 30/31
conceptus tissues: chorion (CHR), allantochorion (ALC) and yolk sac
(YS). The data represent the median for 3 individual conceptuses. Copy
numbers were normalized to 225 000 copies of the housekeeping
gene SDHA and data were expressed as fold change over BMP4 copy
number in the chorionic girdle. Data were analyzed by one-way
ANOVA with repeated measures and the post hoc Tukey multiple
comparison test relative to day 27 (B) or by one sample t test (* P 
.05 (0.0136) relative to chorionic girdle), allantochorion relative to
chorionic girdle  P  .065). B. Qualitative temporal expression of
BMP4 mRNA in chorionic girdle tissue from day 27, 30, 31 and 34
conceptuses. The data represents 3 individual conceptuses. Equine
testis and nonpregnant uterus were used as control tissues (lanes
marked C). C. Quantitative temporal relative expression of BMP4
mRNA in chorionic girdle between days 27 and 34. Data represents
median values for four independent conceptuses for each
developmental stage (* P  .05).
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signaling prior to, during and after terminal differentia-
tion of CG-secreting chorionic girdle trophoblast cells us-
ing both in vivo generated trophoblast tissues and ex vivo
pure trophoblast cell populations that had experienced
minimal manipulation. We found that chorionic girdle
cells expressed the receptors for BMP4 in vivo and func-
tionally differentiated in response to BMP4 in vitro. We
alsodemonstrated that SMAD1/5activity in chorionic gir-
dle in vivo directly correlates with terminal differentiation
of chorionic girdle trophoblast with peak SMAD1/5 ac-
tivity evident at the initiation of chorionic girdle differen-
tiation. A number of reports have demonstrated that
BMP4 can drive ESCs down a trophoblast lineage (35–39)
across a number of species but the question remains as to
whether a requirement for BMP4 is specific to differenti-
ation of ESCs or whether it is a physiologically relevant
factor regulating differentiation of committed primary
trophoblast in vivo. Here we provide the first evidence of
a role for BMP signaling in vitro in primary trophoblast
cells and activity of the BMP pathway in vivo at specific
periods in early placental development that directly cor-
relate with trophoblast differentiation.
A number of positive and negative regulators of TGF
signaling through SMAD2/3 have been shown to play a
role in regulating trophoblast function (22, 25) and/or are
dysregulated in pre-eclamptic placentas (27, 29). We ini-
tially mined a microarray dataset for expression of recep-
tors in the chorionic girdle that can bind the ligand
TGF1, a TGF ligand that is rapidly increased in the
endometrium around the time of chorionic girdle devel-
opment and implantation (2, 13). A comparison of TGF
receptor expression between chorionic girdle and the ad-
jacent chorion highlighted that the chorionic girdle pref-
erentially expressed the receptors BMPR1A and BMPR2,
with little evidence of regulation of receptors that bind
TGF1. BMPR1A and BMPR2 are genes that encode pro-
teins that form a heterodimeric complex that can bind the
ligands BMP2, BMP4 and BMP7 and signal through
SMAD1/5/8. These two receptors are also expressed in the
elongating bovine conceptus (day 17, pre implantation)
and the undifferentiated bovine trophoblast cell line, CT1
(48). We have also demonstrated expression of BMPR1A
and BMPR2 in first trimester human chorionic villous tis-
sues (SI Figure 1). The expression of BMPR1A and
BMPR2 in the early equine, human and bovine placenta
led us to propose that TGF signaling through the alter-
native pathway, SMAD1/5/8, may also have a conserved
and important function in early mammalian placentae.
As far as we are aware, BMP4 expression has not been
studied or reported in placental or endometrial/decidual
tissues previously. A closely related familymember BMP2
has been described in human decidual cells (22). During
the period of initiation of differentiation (day 30–31), we
found BMP4 expression levels in the chorion, allantocho-
rion, and yolk sac were between 20–60 fold higher than
in the chorionic girdle. This suggests that BMP4 is likely to
predominantly regulate terminal differentiation of tro-
phoblast in the chorionic girdle through paracrine mech-
anisms from these adjacent tissues. Following activation
of SMAD1/5 in the chorionic girdle at day30,weobserved
a decrease in BMP4mRNA in the chorionic girdle at days
31 and 34. TGF ligand signaling has been shown to also
lead to inhibition of expression of the ligand itself, possi-
bly explainingwhy intrinsic expression of the ligand is lost
immediately following the initiation of differentiation.
In these studies, we also provide evidence of BMP sig-
naling in the chorionic girdle in vivo. Phosphorylated
SMAD1/5 expression, indicative of BMP signaling, was
higher in the chorionic girdle compared to adjacent cho-
rion and peaked at day 30–31 in the chorionic girdle cor-
relating with the initiation of trophoblast differentiation
in vivo (3, 6). This regulation of SMAD1/5 signaling was
specific and in contrast to stable activity of the alternative
SMAD2 pathway. Indeed, activity of the SMAD2/3 path-
way was not specific to the chorionic girdle and was more
likely to have a housekeeper role during this phase of tro-
phoblast development in the horse. For example, it may
play a role in maintaining proliferation in these tissues
during what is a rapid period of placental growth. Phos-
pho-SMAD5 activation decreased again in the chorionic
girdle at day 34 of pregnancy, a stage when most of the
trophoblast cells have already terminally differentiated. It
is plausible that this decrease in SMAD1/5 signaling may
be regulated at the level of the receptor and supporting this
possibilitywe also observed adecrease in the expressionof
BMPR2 at day 34 when compared with days 27–31.
Studiesof themechanisms that regulatehumanprimary
trophoblast differentiation are challenging primarily due
to the limited availability of placental tissue during key
windows in early trophoblast differentiation, and techni-
cal difficulties in separating the trophoblast cells from the
surrounding decidual cells (49). Consequently, much at-
tention has been given to developing suitable models of
human trophoblast differentiation. One such model is the
study of differentiation of hESCs (49). A number of early
reports demonstrated that BMP4 can drive hESCs down a
trophoblast lineage (35–39) but this model was brought
into question more recently by Bernando et al who state
that BMP4 drives hESC to differentiate primarily towards
mesoderm rather than trophoblast (50). They also found
that themethylation state of the BMP induced cells did not
reflect primary trophoblast. Since this conflicting report
there has been great effort to further elucidate the role of
BMP4 in the hESC model. Amita et al report BMP4 con-
8 Terminal differentiation of trophoblast by BMP4 Endocrinology
The Endocrine Society. Downloaded from press.endocrine.org by [${individualUser.displayName}] on 01 July 2014. at 05:15 For personal use only. No other uses without permission. . All rights reserved.
version of hESC to a cell type that expresses a full range of
trophoblast markers, has invasive properties and secretes
hCG (47). In comparison to human ESC induced to dif-
ferentiate towards trophoblast, equine chorionic girdle
trophoblast have lost Eomesodermin (EOMES) expres-
sion (3), a transcription factor required for trophoblast
stem cell renewal (51). Thus the results reported here re-
flect an observed effect of growth factors on the differen-
tiation of a pure population of fully ‘committed’ tropho-
blast as they differentiate into subpopulations of
trophoblast cells such as those cells that terminally differ-
entiate to secrete CG.
We identified that 100 ng/ml BMP4 alone resulted, af-
ter 72 hours, in a doubling of the number of terminally
differentiated day 30/31 chorionic girdle trophoblast cells
most likely by promoting terminal differentiation as pro-
liferation was not induced with treatment. Response to
this treatmentwas very tightly regulated and developmen-
tal stage dependent, with the greatest response to treat-
ment in day 31 cells. The differentiation of these cells was
deemed functionally active as we observed that BMP4 in-
duced day 31, but not day 30, cells to secrete eCG com-
pared to vehicle treated immature nonsecreting day 30/31
cells. Further, BMP4 did not enhance CG secretion from
terminally differentiated day 34 trophoblast (Figure 2F,
positive control). This supports a role for BMP4 in driving
phenotypic change in the trophoblast, therefore leading to
the attainment of an altered differentiation state that in-
duces CG expression as opposed to being, specifically, a
direct inducer of CG subunit gene expression and/or se-
cretion. In the horse at least, these observations also high-
light the very narrow period in development when differ-
entiation events may be initiated and demonstrate the
crucial importance of carefully assessing tissue responses
at a number of carefully selected windows in early pla-
cental development.
Reflecting the mutually opposing interplay that has
been reported between SMAD2/3 and SMAD1/5/8 signal-
ing (52, 53), blocking of the SMAD2/3 pathway alone
with an inhibitor of the receptors ACVR1B/TGFBR1/
ACVR1C resulted in a similar level of differentiation to
BMP4 alone. Maximal effect on differentiation was
achieved though when BMP4 was combined with the in-
hibitor of SMAD2/3 signaling.The exactmechanisms that
mediate this inhibitory action of SMAD2/3 signaling on
BMP signaling in trophoblast is yet to be determined. In
mouse mesenchymal cells (C2C12 cell line) (52) and
mouse embryonic stem cells (54), TGF and Nodal re-
spectively, can inhibit BMP signaling, activation of
SMAD1/5 and induction of BMP responsive genes via reg-
ulation of inhibitory SMAD7. Inmouse alveolar epithelial
type II cells, TGF also has been shown to inhibit BMP
signaling but in this case acting through antagonism in
phosphorylationsof theSMADs (53). In thehorse,TGF1
is rapidly upregulated in the endometrium between days
30 and 40 of pregnancy, corresponding to the time when
the rate of trophoblast differentiation is rapidly decreas-
ing. Future studies that investigate the possible role of
TGF and Nodal in inhibition of chorionic girdle differ-
entiation are warranted (13).
In conclusion, our findings support a role for BMP4
signaling in the regulation of terminal differentiation of
primary equine trophoblast cells via activation of the
SMAD1/5 pathway (Figure 6). The observation of BMP4
signaling in primary trophoblast provides a previously un-
reported mechanism of TGF signaling in the placenta
that is likely to be conserved across other mammalian
species.
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